CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

CPHI Returns to the Messe Frankfurt in 2025

The Heart of Pharma will return to Europe’s leading pharma manufacturing region

The world’s largest pharmaceutical event, CPHI Europe, will return to Messe Frankfurt in 2025, scheduled for 28-30 October. The event will bring together the entire supply chain, from ingredients and finished dosages to machinery, bio, packaging, and more.

The exhibition is poised to host upwards of 2,400 exhibitors and over 62,000 attendees from 170 countries, presenting unparalleled networking opportunities and access to the global supply chain. CPHI events serve as crucial indicators of industry strength, with a resurgence in growth forecasted by the majority of analysts for 2025. Significantly for the return to Frankfurt, Germany stands out prominently in the latest CPHI annual survey results, ranking highest in API quality manufacturing and second in Bio Innovation Level, Finished Dosage Quality, and Quality of Biological Processing.

“We are excited to bring our flagship event back to Messe Frankfurt, confident in our ability to deliver the world-class experience customers expect. Each year, CPHI attracts a significant number of international exhibitors and visitors, and Messe Frankfurt’s prime location with strong travel connections makes it the perfect venue. This setting enables us to unite key players from across the global supply chain at the heart of the pharmaceutical industry,” said Adam Andersen, Executive Vice President, Pharma, at Informa Markets.

CPHI empowers pharma leaders to make meaningful connections, with a wide range of networking and learning opportunities. The event will also feature content sessions where some of the industry’s biggest names will share insight spanning every facet of industry development and growth. In 2025, the event will see an expanded BioProduction Zone, alongside increased demand for diverse supply chain partners from pharma customers.

The Vice President of Guest Events at Messe Frankfurt, Michael Biwer, stressed that: “This highly international guest event is of immense importance for Frankfurt as a trade fair location. The CPHI exhibition has been held here before, and we see this decision as confirmation of our expertise. It is a great pleasure for us to welcome so many highly qualified participants from the realms of science and research to Messe Frankfurt.”

Over the event’s three days, 28-30 October, Messe Frankfurt will become a hub for the world of pharmaceutical research, development, and manufacturing, empowering the industry with partnerships to launch both innovative and targeted therapies, as well as more affordable and accessible pharmaceuticals.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026